Overleg:Enrofloxacine: verschil tussen versies

Huidige versie van 22 jan 2014 om 20:41

Breakpoints determined for oral dosing of enrofloxacin for cats and dogs by the National Committee for Clinical Laboratory Standards (R-87; 88)

*Flexible indicates the availability of an FDA-approved Flexible Label; the pathogens originating from dermal, respiratory tract, and other tissues could be considered susceptible with an MIC ≤2 if appropriate dosing, explained in the package insert, is used (R-86; 87).